Physician profile
Joseph C Mitro
NPI 1043268873
$6,272.47
in general payments reported to CMS, 2019-2025
18 companies · $3,713 in 2025
The $3,713 reported for 2025 was more than what 96% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2020: $59.38 · 2021: $12.19 · 2022: $266 · 2023: $291 · 2024: $1,777 · 2025: $3,713.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,100 · Travel and Lodging: $1,889 · Food and Beverage: $792.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,099.99 |
| Travel and Lodging | $1,888.84 |
| Food and Beverage | $791.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,905.83 | 2024-2025 | |
| Organon LLC | $343.62 | 2022-2025 | Nexplanon, Nuvaring |
| Hologic Sales and Service, LLC | $213.50 | 2023-2025 | Thinprep 2000 Processor, Aptima, Acessa Provu System |
| Astellas Pharma US INC | $192.75 | 2022-2025 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $134.46 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $61.55 | 2024 | |
| Abbvie INC. | $60.03 | 2019-2022 | |
| Sage Therapeutics, LLC | $57.48 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $57.05 | 2019-2022 | |
| Minerva Surgical, INC | $36.96 | 2023 | |
| Pfizer INC. | $34.81 | 2022 | |
| Roche Diagnostics Corporation | $34.59 | 2019 | |
| Innovation Technologies INC | $34.18 | 2022 | |
| Ethicon US, LLC | $32.29 | 2023 | Enseal |
| Avion Pharmaceuticals | $26.81 | 2019-2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mycovia Pharmaceuticals, INC. | $16.21 | 2023 | Vivjoa |
| Coopersurgical, INC. | $15.90 | 2020 | |
| Allergan, INC. | $14.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Mitro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.